CD8A and cancer: These results demonstrate that the cancer stemness of PDAC may impede the infiltration of the adaptive immune system and that PDACs with high stemness tend to have fewer tumour-infiltrating NK cells and CD8+ T cells which can be primed and activated for immunotherapy.